Pioneering a Healthier Europe with I3-INSHAPE
As Europe faces increasing challenges related to inactive lifestyles and chronic diseases, the I3-INSHAPE project, led by Blautic, emerges as a beacon of innovation and
Onalabs, Member of the New DTX Consortium to Drive Adoption of Digital Therapies in Spain
Onalabs, a member of the new DTX Consortium, is working to drive the adoption of digital therapies in Spain.
On November 29th, Xavi Muñoz participated in the official presentation of the DTX Consortium. This is a public-private alliance formed by prominent representatives from the healthcare ecosystem, with the aim of promoting regulation and speeding up the time-to-market for digital therapies in Spain.
The consortium includes major pharmaceutical companies such as Angelini Pharma, Bayer, Boehringer Ingelheim, Ferrer, Merck, and Pfizer, as well as other large companies in the digital health sector like Teladoc Health, and a small number of startups, including Onalabs.
This presents a great opportunity to strengthen corporate and business ties, positioning Onalabs as a key company in the national healthcare ecosystem.
Here is the link to the press release.
Other Entries
Barça Innovation Hub new strategic partner
It has been hard to keep silent, but we can finally announce it: we have incorporated the Barça Innovation Hub (BIHUB) as a strategic partner
Lactate, Key to Optimizing Performance in Basketball
>Increasingly, the world of basketball, especially at the high competition level, demands high levels of performance from its players, sometimes reaching extreme levels. These days,
